Platelet transfusions improve hemostasis and survival in a substudy of the prospective, randomized PROPPR trial

Authors: Jessica C. Cardenas, Xu Zhang, Erin E. Fox, Bryan A. Cotton, John R. Hess, Martin A. Schreiber, Charles E. Wade, John B. Holcomb - Blood Advances 2018 cited by 156

< .05); however, no differences in hospital- or ICU-free days were observed. In conclusion, early platelet administration is associated with improved hemostasis and reduced mortality in severely injured, bleeding patients. This trial was registered at www.clinicaltrials.gov as # NCT01545232.